Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?

about

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?

Item

http://www.wikidata.org/entity/Q54203490

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Reduction of Vascular Inflamma ...... on from Cardiovascular Events?

@en

Reduction of Vascular Inflamma ...... on from Cardiovascular Events?

@nl

type

Item

label

Reduction of Vascular Inflamma ...... on from Cardiovascular Events?

@en

Reduction of Vascular Inflamma ...... on from Cardiovascular Events?

@nl

prefLabel

Reduction of Vascular Inflamma ...... on from Cardiovascular Events?

@en

Reduction of Vascular Inflamma ...... on from Cardiovascular Events?

@nl

P1476

Reduction of Vascular Inflamma ...... on from Cardiovascular Events?

@en

P2093

Andromachi Reklou

http://www.w3.org/2001/XMLSchema#string

Dimitris Patoulias

http://www.w3.org/2001/XMLSchema#string

Konstantinos Imprialos

http://www.w3.org/2001/XMLSchema#string

Konstantinos Stavropoulos

http://www.w3.org/2001/XMLSchema#string

Michael Doumas

http://www.w3.org/2001/XMLSchema#string

Vasilios G Athyros

http://www.w3.org/2001/XMLSchema#string

P2860

Statins for acute coronary syndrome

C-reactive protein (CRP)-lowering agents

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Inflammation in atherosclerosis: from pathophysiology to practice

P304

29-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874192401812010029

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29785212

http://www.w3.org/2001/XMLSchema#string

P921

inflammation

P932

5897979

http://www.w3.org/2001/XMLSchema#string